844501-00-4

Basic information

• Product Name: [1-(TERT-BUTOXYCARBONYL)-1,2,3,6-TETRAHYDROPYRIDIN-4-YL]BORONIC ACID
• Synonyms: -1,2,3,6-tetrahydropyridin-4-yl);[1-(TERT-BUTOXYCARBONYL)-1,2,3,6-TETRAHYDROPYRIDIN-4-YL]BORONIC ACID;[1-(TERT-BUTOXYCARBONYL)-1,2,3,6-TETRAHYDROPYRIDINE-4-YL]BORONIC ACID;1(2H)-Pyridinecarboxylic acid, 4-borono-3,6-dihydro-, 1-(1,1-dimethylethyl) ester (9CI);1-(tert-Butoxycarbonyl)-1,2,3,6-tetrahydropyridine-4-boronic acid;1,2,3,6-Tetrahydropyridine-4-boronic acid, N-BOC protected;N-BOC-1,2,3,6-tetrahydropyridin-4-ylboronic acid;1(2H)-Pyridinecarboxylic acid, 4-borono-3,6-dihydro-, 1-(1,1-diMethylethyl) ester
• CAS NO: 844501-00-4
• Molecular Formula: C₁₀H₁₈BNO₄
• Molecular Weight: 227.07
• Mol File: 844501-00-4.mol

Chemical Properties

• Boiling Point: 370.3±52.0 °C(Predicted)
• Appearance: /
• Density: 1.15±0.1 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 9.13±0.20(Predicted)
• CAS DataBase Reference: [1-(TERT-BUTOXYCARBONYL)-1,2,3,6-TETRAHYDROPYRIDIN-4-YL]BORONIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: [1-(TERT-BUTOXYCARBONYL)-1,2,3,6-TETRAHYDROPYRIDIN-4-YL]BORONIC ACID(844501-00-4)
• EPA Substance Registry System: [1-(TERT-BUTOXYCARBONYL)-1,2,3,6-TETRAHYDROPYRIDIN-4-YL]BORONIC ACID(844501-00-4)

Safety Data

• Hazardous Substances Data: 844501-00-4(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
[1-(TERT-BUTOXYCARBONYL)-1,2,3,6-TETRAHYDROPYRIDIN-4-YL]BORONIC ACID is used as a reagent for the formation of carbon-carbon and carbon-heteroatom bonds, facilitating the synthesis of complex organic molecules.
Used in Drug Discovery:
In the pharmaceutical industry, [1-(TERT-BUTOXYCARBONYL)-1,2,3,6-TETRAHYDROPYRIDIN-4-YL]BORONIC ACID is used as a building block for the development of potential pharmaceutical agents, contributing to the creation of new medicines with improved therapeutic properties.

Upstream product

• 375853-82-0 tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-1(2H)-pyridinecarboxylate 

Downstream Products

• 1403595-56-1 tert-butyl 4-(3-(cyclopentyl(methyl)amino)-5-(((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)carbamoyl)-4-methylphenyl)-5,6-dihydropyridine-1(2H)-carboxylate 
• 1239363-36-0 tert-butyl 4-(2,6-dichloropyridin-4-yl)-5 ,6-dihydropyridine-1(2H)-carboxylate 

Relevant articles and documents

Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibition by Optimization of the 2-Aminopyridine-Based Scaffold with a Pyridine Linker

Neuronal nitric oxide synthase (nNOS) is an important therapeutic target for the treatment of various neurodegenerative disorders. A major challenge in the design of nNOS inhibitors focuses on potency in humans and selectivity over other NOS isoforms. Here we report potent and selective human nNOS inhibitors based on the 2-aminopyridine scaffold with a central pyridine linker. Compound 14j, the most promising inhibitor in this study, exhibits excellent potency for rat nNOS (Ki = 16 nM) with 828-fold n/e and 118-fold n/i selectivity with a Ki value of 13 nM against human nNOS with 1761-fold human n/e selectivity. Compound 14j also displayed good metabolic stability in human liver microsomes, low plasma protein binding, and minimal binding to cytochromes P450 (CYPs), although it had little to no Caco-2 permeability.

INHIBITORS OF FATTY ACID AMIDE HYDROLASE

Provided herein are compounds of formula (I): or pharmaceutically acceptable salts, solvates or prodrugs thereof or mixtures thereof, wherein Z1, Z2, X1, X2, X3, R1, R2 R3/

4-CARBOX PYRAZOLE DERIVATES USEFUL AS ANTI-VIRAL AGENTS

Novel antiviral compounds of Formula (I) : wherein: A represents hydroxy; R1 represents aryl, heteroaryl bonded through a ring carbon atom, or heterocyclyl bonded through a ring carbon atom, C1-6alkyl or -C5-9cycloalkyl, each of which may be optionally su